Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Recombinant LH in Late Phase of Ovarian Stimulation
NCT03204253Completed
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2016
- Primary completion
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised, open-label trial of lutropin alfa in female infertility (2 arms), sponsored by Sapienza University of Rome. Primary endpoint: Number of oocytes retrieved at 14 days. Started Jan 2016; status: completed.
02
Drugs
lutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT03204253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03204253.